Stalicla S.A.

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2024-01-11

Patent Grants:

Last grant date:

2025-10-07

Top Inventors for applications by Stalicla S.A.

These are the the leading inventors for applications assigned to Stalicla S.A.:

Lynn Durham 9 Geneva, Switzerland
Lynn DURHAM 1 Geneve, Switzerland
Jean-Marc Hyvelin 1 Geneva, Switzerland
Jean-Marc Hyvelin 1 Geneve, Switzerland

Recent patent applications by Stalicla S.A.

Stalicla S.A. based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-01-11 ✅ Patent 12,435,353 granted on 2025-10-07

US20240011071A1

Chemistry; metallurgy

BIOMARKER ASSAY FOR USE IN MONITORING AUTISM

#2 | 2022-01-06 ✅ Patent 12,474,327 granted on 2025-11-18

US20220003753A1

Physics

METABOLIC PROFILING FOR THE DIAGNOSIS OF A SUBSET OF IDIOPATHIC AUTISM SPECTRUM DISORDER PATIENTS, ADS PHENOTYPE 1

#3 | 2021-06-10

US20210169993A1

Human necessities

TREATMENT OF A SUBTYPE OF ASD

#4 | 2021-05-27

US20210154177A1

Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

#5 | 2021-05-20 ✅ Patent 11,439,627 granted on 2022-09-13

US20210145803A1

Human necessities

Pharmaceutical composition for the treatment of autism

#6 | 2019-05-09 ✅ Patent 11,357,871 granted on 2022-06-14

US20190134230A1

Human necessities

Challenge test for diagnosing subtypes of ASD

#7 | 2019-05-09 ✅ Patent 11,364,311 granted on 2022-06-21

US20190134229A1

Human necessities

Method of identifying ASD phenotype 1 patients

#8 | 2019-05-09 ✅ Patent 11,040,117 granted on 2021-06-22

US20190134152A1

Human necessities

Treatment of a subtype of ASD

#9 | 2019-05-09 ✅ Patent 10,940,140 granted on 2021-03-09

US20190134011A1

Human necessities

Pharmaceutical composition for the treatment of autism

Also check out Stalicla S.A.'s (Geneva, Switzerland) applicant profile with 9 patent applications submitted.

AssigneeID:

147926 ⎘